A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
for Metastatic Castration-resistant Prostate Neoplasms
53 locations incl. La Jolla
Sponsor: Janssen Research & Development, LLC
Sex: Male·Age: 18+
Code: NCT07164443·Phase 3·Recruiting·Listed Sep 2025